These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 116266)

  • 1. Effects of zimelidine, a selective 5-HT uptake inhibitor, on serum prolactin levels in man.
    Syvälahti E; Nagy A; van Praag HM
    Psychopharmacology (Berl); 1979 Sep; 64(3):251-3. PubMed ID: 116266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of serotonin (5-HT) in the control of TSH and prolactin release in euthyroid subjects as assessed by the administration of ketanserin (5-HT2 antagonist) and zimelidine (5-HT re-uptake inhibitor).
    O'Malley BP; Jennings PE; Cook N; Barnett DB; Rosenthal FD
    Psychoneuroendocrinology; 1984; 9(1):13-9. PubMed ID: 6234610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function.
    Syvälahti E; Eneroth P; Ross SB
    Psychiatry Res; 1979 Oct; 1(2):111-20. PubMed ID: 121774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.
    Fuxe K; Ogren SO; Agnati LF
    Neurosci Lett; 1979 Aug; 13(3):307-12. PubMed ID: 530482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor.
    Aberg A; Holmberg G
    Acta Psychiatr Scand; 1979 Jan; 59(1):45-58. PubMed ID: 369299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.
    Gebhart GF; Lorens SA
    Br J Pharmacol; 1980 Nov; 70(3):411-4. PubMed ID: 6449224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of ethanol intake by 5-hydroxytryptamine uptake blockade in laboratory rats. I. Involvement of brain 5-hydroxytryptamine in the mediation of the positive reinforcing properties of ethanol.
    Rockman GE; Amit Z; Carr G; Brown ZW; Ogren SO
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):245-59. PubMed ID: 526079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.
    Ferrari C; Caldara R; Romussi M; Rampini P; Telloli P; Zaatar S; Curtarelli G
    Neuroendocrinology; 1978; 25(6):319-28. PubMed ID: 662080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients.
    Johansson F; Von Knorring L
    Pain; 1979 Aug; 7(1):69-78. PubMed ID: 388295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-hydroxytryptamine uptake blockers on the release of LH and prolactin in several different experimental steroid models in the rat.
    Horn AM; Fink G
    J Endocrinol; 1985 Mar; 104(3):397-406. PubMed ID: 3156201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
    Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.
    Schenk GK; Filler W; Ranft W; Zerbin D
    Acta Psychiatr Scand Suppl; 1981; 290():303-13. PubMed ID: 6452797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin.
    Jørgensen H; Kjaer A; Warberg J; Knigge U
    Neuroendocrinology; 2001 May; 73(5):322-33. PubMed ID: 11399905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.
    Siwers B; Ringberger VA; Tuck JR; Sjöqvist F
    Clin Pharmacol Ther; 1977 Feb; 21(2):194-200. PubMed ID: 837638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
    Coppen A; Rama Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 May; 63(2):125-9. PubMed ID: 112630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.
    Holsboer F; Müller OA; Winter K; Doerr HG; Sippell WG
    Psychopharmacology (Berl); 1983; 80(1):85-7. PubMed ID: 6306711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.